Directory profiles that have not opted in. Name, email, and a private contact are not listed. 52 states. Last updated 2026-10-16. Counts are on the catalog.
Page 790. The contact email is not on this page.
- VYLUMA INC.
NIH R43: Development of a safe and effective topically administered pharmacotherapy to treat acute corneal pain
startup · NJ · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- SIEYAX, INC
NIH R41: Preclinical Studies to Develop an Eya2 Tyr Phosphatase Inhibitor as a Novel Medulloblastoma Therapeutic
startup · CO · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ATTOGENE
NIH R43: Development of a novel electrochemical pesticide sensor
startup · TX · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- KULEON LLC
NIH U43: Novel and functionally selective 5-HT2C receptor agonist for treating Alcohol Use Disorder
startup · WA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- AcousticaBio
AcousticaBio is a preclinical biotechnology company focused on solving drug delivery challenges using proprietary acoustophoretic technology to create ultra-high concentration antibody formulations for subcutaneous injections.
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Scion Neurostim, Inc.
Form D history: Biotechnology
startup · NC · amount not stated · 2023-10-19
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2023-10-19.
- PROACTIVE MEMORY SERVICES, INC.
NIH R44: CUSTOMIZABLE TRAINING SOFTWARE FOR PROFESSIONAL ALZHEIMER DIRECT CARE PROVIDERS
startup · UT · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- COMPOVAX, LLC
NIH R41: Capless mRNA for use as a vaccine
startup · AL · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- FOX LEARNING SYSTEMS, INC.
NIH R44: Development and Randomized Clinical Trial of an App-based Intervention to Reduce Postpartum Depression in High-Risk Women
startup · PA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Claria Medical, Inc.
Form D history: Other Health Care
startup · CA · amount not stated · 2021-06-11
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2021-06-11.
- DELAQUA PHARMACEUTICALS INC
NIH R43: P-gp inhibitor polymeric micelle platform for enhanced drug solubilization and oral bioavailability
startup · NC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- VIGILANT LABORATORIES LLC
NIH R44: Development of an effective, low-cost, point-of-care early detection test for oral cancer in low resource settings
startup · FL · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- RheumaGen, Inc.
Form D history: Biotechnology
startup · CO · amount not stated · 2024-04-17
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2024-04-17.
- LIMAX BIOSCIENCES INC
NIH R44: Advanced Hemostatic Adhesive Hydrogel System for Postpartum Hemorrhage Control
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- PLUREXA LLC
NIH R42: Targeting Myosin to Treat Polycystic Kidney Disease
startup · WA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- MASSMATRIX, INC.
NIH R41: Advancing Native Mass Spectrometry Analysis with Easier, Faster and More Accurate Intact Mass Deconvolution for Proteins and Nucleic Acids
startup · OH · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Invenio Imaging
startup · CA · amount not stated · 2021-02-09
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2021-02-09.
- SPATIAL GENOMICS, INC.
NIH R44: Multi-modal spatial genomics in the mouse and human brains
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- SCARAB GENOMICS, LLC
NIH R44: An improved low-endotoxin Clean Genome E. coli strain for production of biological products
startup · WI · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ADVANCED SMART SYSTEMS/EVALUATION TECHNO
NIH R42: Mitigating Injurious Falls in Older Adults Through Non-Injurious Fall and Gait Analysis From Floor Vibrations
startup · SC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- LIFE ANALYTICS, INC.
NIH R44: Optimization of an at-home continuous multi-domain monitoring and assessment system to improve Alzheimer's and related disorders clinical trials
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- NEUROGT, INC.
NIH R41: Novel AAV gene therapy for treating CNS neuropathy of MPS IIIC
startup · NC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- MOLECULAR EXPRESS, INC.
NIH R44: Preclinical Development of a ME-1001, a Synthetic Lung Surfactant
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- FORTISCIENCE, INC.
NIH R41: Development of a Small Molecule Inhibitor of Fortilin for Atherosclerosis Treatment and Prevention
startup · DE · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Kuleana Technology, Inc.
Form D history: Biotechnology
startup · WA · amount not stated · 2022-04-25
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2022-04-25.
- NEW YORK/R&D/CTR/TRANSLATIONAL MED/THER
NIH R44: Exosome drug for tendinopathy
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- TRIPLE RING TECHNOLOGIES, INC.
NIH R44: Virtual dose mapping for radiation sterilization
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- SPINEX, INC.
NIH R44: Spinal Cord Innovation in Pediatrics to Treat Cerebral Palsy (SCiP Clinical Study)
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- CAMINO PHARMA, LLC
NIH U43: Preclinical validation of mGlu2 PAMs in alcohol use disorder
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- EndoTheia, Inc.
Form D history: Biotechnology
startup · TN · amount not stated · 2024-09-18
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2024-09-18.
- BACKYARD BRAINS, INC.
NIH R44: Introducing Neuroscience and Neurocomputation Concepts to High School Students using Brain-based Neurorobots
startup · MI · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Hemex Health
Hemex Health is focused on redefining healthcare delivery through accessible diagnostics, particularly in challenging clinical environments. Their Gazelle platform provides accurate, affordable, and accessible diagnostic solutions for blood-based conditions.
startup · OR · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- HELP-FULL INC
NIH R43: Token-Based Community Network to Help Family Caregivers of Adults with Alzheimer's Disease and Related Dementias
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- SIGNATURE DIAGNOSTICS INC
NIH R41: Development of a Stool-Based Screening Method for the Early Detection of Necrotizing Enterocolitis in Premature Neonates
startup · PA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Savanna Biotherapeutics, Inc.
Form D history: Biotechnology
startup · CA · amount not stated · 2025-06-30
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2025-06-30.
- ACCEL DIAGNOSTICS, LLC
NIH R44: A COVID-19 Point of Care Serological Assay for Rapid Quantification of Antibody Titer.
startup · TX · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- BiomEdit
BiomEdit is an innovator in microbiome research, focusing on creating products that enhance animal health through novel microbiome-derived solutions. The company employs advanced techniques in microbiology and AI to develop products that leverage the animal's microbial ecosystem.
startup · IN · amount not stated · 2025-06-26
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2025-06-26.
- SCIENTIFIC HORIZONS CONSULTING LLC
NIH R43: A Novel Aerosolization and Inhalation Platform for the Pulmonary Delivery of Anti-inflammatory Agents to Distal Airways for the Enhanced Pain Management in Chronic Obstructive Pulmonary Disease (COPD)
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- TWILIGHT BIOSCIENCE, INC.
NIH U44: A HERV-K (HML-2) Immunization Strategy for the Treatment and Prevention of Amyotrophic Lateral Sclerosis
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- AQUALUNG THERAPEUTICS CORP.
NIH R42: Preclinical Development of a Novel eNAMPT-Neutralizing mAb for Pulmonary Hypertension
startup · FL · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.